Pyrazolyl borates complexes-(LAW294)
FIELD OF THE INVENTION 
     This invention relates a new class of compounds. More specifically, it relates to metal complexes having pyrazolyl borate ligands substituted with fluoroalky groups near the metal center. 
     BACKGROUND OF THE INVENTION 
     Pyrazolyl borates are a well known class of organic ligands, described most recently in several review articles: S. Trofimenko Chem. Rev 1993, 93, 943; S. Trofimenko Prog. Inorg. Chem. 1986, 34, 115. Metal complexes of organic ligands of the pyrazolyl borate class bearing mixed electron releasing-electron withdrawing substituents, like the trifluoromethyl group are rare. Only the K, Rh and Ir salts of hydrotris (3-(trifluoromethyl)-5-methylpyrazo-1-1-yl) borate, have been prepared and characterized. See C. K. Ghosh, J. K. Hoyano, R. Krentz, W. A. G. Graham, J. Am. Chem. Soc. 1989, 11 5480. Only K and Rh metal complexes of dihydro bis(3-(trifluoromethyl)-5-methylpyrazol-1-yl) borate, have been reported. See R. Krenz, Ph.D. Thesis, &#34;Model Compounds in C--H Activation&#34;, University of Alberta, 1989). 
     SUMMARY OF THE INVENTION 
     The present invention comprises a composition of matter having the formula M x  L y  P z .nQ where M is a metal ion, L is a fluoralkyl substituted bis or tris pyrazole borate anion, or a mixture thereof, P is a counterion, x, y, and z are integers sufficient to render the composition electrically neutral, Q is a solvent, and n is a numerical value of from 0 to about 12. 
     The metal complexes and especially the cobalt complex of the tris pyrazolyl borate anion are useful as oxidation catalysts. 
    
    
     BRIEF DESCRIPTION OF THE DRAWINGS 
     FIG. 1 is a perspective drawing of one complex of the invention, Co[(C 5  H 4  N 2  F 3 ) 3  BH](NO 3 )(NCCH 3 ), with all non hydrogen atoms represented by thermal vibration ellipsoids drawn to encompass 50% of their electron density, and hydrogen atoms arbitrarily represented by small spheres. In the figure, one of the CF 3  groups is shown to have 2 alternate orientations about the (C 23  -C 26 ) C--CF 3  bond in the lattice. The major (68%) orientation for the fluorine atoms is represented by solid C--F bonds and specified by atoms F 21 , F 22  and F 23  ; the minor (32%) orientation is represented by open C--F bonds and specified by atoms F 21  &#39;, F 22  &#39;, and F 23  &#39;. 
     FIG. 2 shows a perspective drawing of another complex of the present invention, Cu[(C 5  H 4  N 2  F 3 ) 2  BH 2  ] 2 , with non hydrogen atoms represented by thermal vibration ellipsoids drawn to encompass 50% of their electron density and hydrogen atoms arbitrarily represented by small spheres. One of the CF 3  groups per ligand is shown to have 2 alternate orientations in the lattice. The major (85%) orientation for the fluorine atoms is specified by atoms F 21 , F 22  and F 23  (represented by solid C--F bonds) and the minor (15%) orientation is specified by F 24 , F 25  and F 26  (represented by open C--F bonds). 
    
    
     DETAILED DESCRIPTION OF THE INVENTION 
     The compounds of the present invention have the formula M x  L y  P z .nQ wherein M is a metal ion selected from transition and lanthanide metals; and L is a fluoroalkyl substituted tris or bis pyrazolyl borate anion, or mixture thereof; and P is a counterion, x, y and z are integers sufficient to render the composition electrically neutral; Q is a solvent, n is a numerical value of from 0 to about 12. In the composition of the present invention, the ligand L has the structure: ##STR2## wherein R 1  is an alkyl group of from 1 to 12 carbon atoms or an aryl or aralkyl group of from 6 to 12 carbon atoms and R 2  is a fluoralkyl group of from 1 to 12 carbon atoms. 
     In the compositions of this invention preferably M is selected from the group consisting of Co, Ni, Zn, Mn, Cr, Zr, Ti, Hf, V, and Fe. 
     Typically, the counterion P will be selected from a halide, such as chloride or bromide, a nitrate, sulfate, a carboxylate of from about 1 to 12 carbon atoms, sulfonate, or borate, such as fluoroborate, and perchlorate. 
     Additionally, the solvent, Q, typically will be water, an alcohol of from about 1 to about 12 carbon atoms, acetonitrile, acetone, or any organic solvent in which the complex is soluble. 
     The compounds of the present invention are prepared by combining a solution of an alkali metal salt, especially the potassium salt of the ligands L 1  or L 2  having the formula: ##STR3## or mixtures of them, with a solution of a salt of the metal, M, where M is as previously defined: suitable salts of the metal, M, include chlorides, bromides, fluorides, nitrates, sulfates, alkyl or aryl sulfonates, fluoroborates, phenyl borates, perchlorates, and carboxylates. Suitable solvent include water, hydrocarbons, ketones (like acetone), nitriles, ethers, alcohols, dimethyl sulfoxide, dimethyl formamide, and the like. The choice of solvents is such as to insure solubility of the ligand, the metal salt or both. 
     Typically, the compounds of the present invention are recovered by fractional crystallization, by precipitation with cosolvents, or by evaporation; however, other known techniques like decanting, filtration and the like, can also be used. 
     Compounds of the present invention are useful as oxidation catalysts. Indeed, one of the advantages of the compounds of the present invention is the presence of oxidation resistant ligands. Indeed, the fluoroalkyl groups near the metal center of the compound provide electron withdrawing groups to the metal center, and may have the resistance of the catalyst toward self-destructive decomposition. 
     The invention will be further illustrated in the following examples: 
     EXAMPLE 1 
     Preparation of [CoL l  (NO 3 ) (CH 3  CN)] 
     To a 10 ml acetonitrile solution of 40 mg (0.14×10 -3  moles) Co(NO 3 ) 2 .6H 2  O were added 60 mg (0.12×10 -3  moles) of solid KL 1 . After 10 minutes of stirring, the solution was filtered and red-purple crystals were isolated and characterized by single crystal X-ray diffraction. The structure is shown in FIG. 1. 
     EXAMPLE 2 
     Preparation of [CoL 1  Cl] 
     To 10 ml acetonitrile solution of 40 mgs (0.17×10 -3  moles) of COCl 2 .H 2  O, 60 mgs (0.12×10 -3  moles) of solid KL 1  was added. After stirring for 10 minutes. red-purple crystals were obtained by slow evaporation. 
     EXAMPLE 3 
     Preparation of Cu(L 2 ) 2   
     To a 20 ml acetone solution of 400 mg (1.08×10 -3  moles) of Cu(ClO 4 ) 2 .6H 2  O were added 760 mg (2.17×10 -3  moles) of KL 2 . After stirring for 10 minutes 60 mg (1.08×10 -3  moles) of KOH was added and the mixture stirred for an additional 20 minutes. Addition of 5 ml of toluene followed by slow evaporation resulted in dark purple crystals which were structurally characterized by single crystal X-ray diffraction. The structure is shown in FIG. 2. 
     EXAMPLE 4 
     Preparation of Cu(L 2 ) 2   
     The procedure of Example 3 was repeated but without adding KOH. The stone product as in Example 3 was obtained. 
     EXAMPLE 5 
     Preparation of [MnL 1  (ClO 4 ) 2  ].n(CH 3  CN) 
     To a 10 ml acetronitrile solution of 45 mg (0.095×10 -3  moles) Mn(ClO 4 ) 2 .6H 2  O was added 65 mg (0.09×10 -3  moles) KL 1 . The mixture was stirred at room temperature for 15 minutes and filtered. Colorless crystals of the title complex were obtained by evaporation. 
     EXAMPLE 6 
     Oxidation of cyclohexane by [CoL 1  (NO 3 )(CH 3  CN)] 
     This example illustrates the use of a metal complex of the invention as an oxidation catalyst. 
     To 10 ml of cyclohexane 1 ml 80% cumyl hydroperoxide in cumene was added, followed by 10 mgs. of [CoL 1  (NO 3 )(CH 3  CN)] dissolved in 5 ml acetonitrile. After stirring for 24 hours at room temperature, GC analysis of the reaction mixture indicated the formation of cyclohexane and cyclohexanone. Cumyl hydroperoxide decomposition products were also observed.